Evidence map›Paper›PMID 27216194›Full record

ArticleCancer research2016

Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway.

Yasminka Jakubek, Wenhua Lang, Selina Vattathil, Melinda Garcia, Li Xu, Lili Huang, Suk-Young Yoo, Li Shen, Wei Lu, Chi-Wan Chow and 17 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Analysis ofInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 4 institutions in 1 country.

Yasminka JakubekDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wenhua LangDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Selina VattathilDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Melinda GarciaDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Li XuDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lili HuangDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Suk-Young YooDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Li ShenDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wei LuDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chi-Wan ChowDepartment of Thoracic Head/Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zachary WeberAvera Institute for Human Genetics, Sioux Falls, South Dakota.
Gareth DaviesAvera Institute for Human Genetics, Sioux Falls, South Dakota.
Jing HuangDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Carmen BehrensDepartment of Thoracic Head/Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Neda KalhorDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cesar MoranDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Junya FujimotoDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reza MehranDepartment of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Randa El-ZeinDepartment of Radiology, Houston Methodist Research Institute, Houston, Texas.
Stephen G SwisherDepartment of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jing WangDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jerry FowlerDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Avrum E SpiraDepartment of Medicine, Boston University, Boston, Massachusetts.
Erik A EhliAvera Institute for Human Genetics, Sioux Falls, South Dakota.
Ignacio I WistubaDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Paul ScheetDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences (GSBS), Houston, Texas. pascheet@mdanderson.org hkadara@mdanderson.org.
Humam KadaraDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences (GSBS), Houston, Texas. pascheet@mdanderson.org hkadara@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USAvera Health · USBoston University · USHouston Methodist · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
TRAINING PROGRAM IN MOLECULAR GENETICS OF CANCERT32CA009299 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOZANO, GUILLERMINA · 1985 to 2014
$4.7M
Statistical Methods for Population Genomics and "Next-gen" Sequencing DataR01HG005859 · NHGRI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SCHEET, PAUL A · 2011 to 2015
$1.9M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA070907NCI NIH HHS T32 CA009299NHGRI NIH HHS R01 HG005859
6 · The paper itself

Abstract

Visually normal cells adjacent to, and extending from, tumors of the lung may carry molecular alterations characteristics of the tumor itself, an effect referred to as airway field of cancerization. This airway field has been postulated as a model for early events in lung cancer pathogenesis. Yet the genomic landscape of somatically acquired molecular alterations in airway epithelia of lung cancer patients has remained unknown. To begin to fill this void, we sought to comprehensively characterize the genomic architecture of chromosomal alterations inducing allelic imbalance (AI) in the airway field of the most common type of lung tumors, non-small cell lung cancer (NSCLC). To do so, we conducted a genome-wide survey of multiple spatially distributed normal-appearing airways, multiregion tumor specimens, and uninvolved normal tissues or blood from 45 patients with early-stage NSCLC. We detected alterations in airway epithelia from 22 patients, with an increased frequency in NSCLCs of squamous histology. Our data also indicated a spatial gradient of AI in samples at closer proximity to the NSCLC. Chromosome 9 displayed the highest levels of AI and comprised recurrent independent events. Furthermore, the airway field AI included oncogenic gains and tumor suppressor losses in known NSCLC drivers. Our results demonstrate that genome-wide AI is common in the airway field of cancerization, providing insights into early events in the pathogenesis of NSCLC that may comprise targets for early treatment and chemoprevention. Cancer Res; 76(13); 3676-83. ©2016 AACR.

Indexed as

Allelic ImbalanceGenome, HumanAdenocarcinomaBiomarkers, TumorCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCase-Control StudiesChromosome AberrationsFollow-Up StudiesGenomicsHigh-Throughput Nucleotide SequencingHumansLungLung NeoplasmsNeoplasm Recurrence, LocalNeoplasm StagingBiomarkers, Tumor

Identifiers

PMID27216194
PMCPMC5393446
OpenAlexW2398928104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.